Ver Publicación - Prisma - Unidad de Bibliometría

Adaptation of clinical isolates of Klebsiella pneumoniae to the combination of niclosamide with the efflux pump inhibitor phenyl-arginine-β-naphthylamide (PaβN): co-resistance to antimicrobials

Pacios, Olga; Fernández-García, Laura; Bleriot, Inés; Blasco, Lucia; Ambroa, Antón; López, María; Ortiz-Cartagena, Concha; González de Aledo, Manuel; Fernández-Cuenca, Felipe; Oteo-Iglesias, Jesús; Pascual, Álvaro; Martínez-Martínez, Luis; Tomás, María 

Tipo: Artículo
Año de Publicación: 2022
Volumen: 77
Número: 5
Páginas: 1272 - 1281
Fuente Nº Citas Fecha Actualización
scopus930-11-2024
wos901-12-2024
Dimensions
PlumX
Altmetric

Año: 2022

Journal Impact Factor (JIF): 5.20

CategoríaEdiciónPosiciónCuartilTercilDecil
PHARMACOLOGY & PHARMACYSCIE55/278Q1T1D2
INFECTIOUS DISEASESSCIE29/96Q2T1D3
MICROBIOLOGYSCIE38/135Q2T1D3

Año: 2022

Journal Citation Indicator (JCI): 1,200

CategoríaPosiciónCuartilTercilDecilPercentil
INFECTIOUS DISEASES24/129Q1T1D281,78
MICROBIOLOGY27/156Q1T1D283,01
PHARMACOLOGY & PHARMACY54/366Q1T1D285,38

Año:

2022

CiteScore:

9,200

CategoríaPosiciónCuartilTercilDecil
Pharmacology (medical)23/260Q1T1D1
Infectious Diseases40/304Q1T1D2
Microbiology (medical)23/124Q1T1D2
Pharmacology46/301Q1T1D2

SJR año:

2022

Factor de Impacto:

1,382

CategoríaPosiciónCuartilTercilDecil
Pharmacology (medical)25/282Q1T1D1
Infectious Diseases50/341Q1T1D2
Microbiology (medical)19/137Q1T1D2
Pharmacology35/326Q1T1D2
No existen datos para la revista de esta publicación.
Agencia Código de Proyecto
GAIN, Xunta de GaliciaIN606A-2020/035; IN606B-2021/013; IN606B-2018/008
Instituto de Salud Carlos III FEDER, Spanish Network for Research in Infectious Diseases (REIPI)RD16/0016/0001; RD16/0016/0006; RD16/CIII/0004/0002
ISCIII-Deputy General Directorate for Evaluation and Promotion of Research -European Regional Development Fund 'A way of Making Europe'-
Miguel Servet Research Programme (ISCIII)-
Miguel Servet Research Programme (SERGAS)-
pFIS programme (ISCIII)FI20/00302
State Plan for R+D+I 2013-2016 (National Plan for Scientific Research, Technological Development and Innovation 2008-2011)PI19/00878
Study Group on Mechanisms of Action and Resistance to Antimicrobials, GEMARA (SEIMC)-
Nota: los datos sobre financiación provienen de la WOS
# Autor Afiliación
1Pacios, OlgaUniversidade da Coruña; Study Group on Mechanisms of Action and Resistance to Antimicrobials (GEMARA) on the behalf of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) (Spain)
2Fernández-García, LauraUniversidade da Coruña; Study Group on Mechanisms of Action and Resistance to Antimicrobials (GEMARA) on the behalf of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) (Spain)
3Bleriot, InésUniversidade da Coruña; Study Group on Mechanisms of Action and Resistance to Antimicrobials (GEMARA) on the behalf of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) (Spain)
4Blasco, LuciaUniversidade da Coruña; Study Group on Mechanisms of Action and Resistance to Antimicrobials (GEMARA) on the behalf of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) (Spain)
5Ambroa, AntónUniversidade da Coruña; Study Group on Mechanisms of Action and Resistance to Antimicrobials (GEMARA) on the behalf of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) (Spain)
6López, MaríaInstituto de Salud Carlos III; Universidade da Coruña; Study Group on Mechanisms of Action and Resistance to Antimicrobials (GEMARA) on the behalf of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) (Spain)
7Ortiz-Cartagena, ConchaUniversidade da Coruña; Study Group on Mechanisms of Action and Resistance to Antimicrobials (GEMARA) on the behalf of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) (Spain)
8González de Aledo, ManuelUniversidade da Coruña (Spain)
9Fernández-Cuenca, FelipeHospital Universitario Virgen Macarena; Instituto de Salud Carlos III; Study Group on Mechanisms of Action and Resistance to Antimicrobials (GEMARA) on the behalf of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) (Spain)
10Oteo-Iglesias, JesúsCentro Nacional de Microbiologia; Instituto de Salud Carlos III; Study Group on Mechanisms of Action and Resistance to Antimicrobials (GEMARA) on the behalf of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) (Spain)
11Pascual, ÁlvaroHospital Universitario Virgen Macarena; Instituto de Salud Carlos III; Study Group on Mechanisms of Action and Resistance to Antimicrobials (GEMARA) on the behalf of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) (Spain)
12Martínez-Martínez, LuisInstituto de Salud Carlos III; Hospital Universitario Reina Sofia; Study Group on Mechanisms of Action and Resistance to Antimicrobials (GEMARA) on the behalf of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) (Spain)
13Tomás, María Instituto de Salud Carlos III; Universidade da Coruña; Study Group on Mechanisms of Action and Resistance to Antimicrobials (GEMARA) on the behalf of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) (Spain)